Bioclinica®, a world-leading provider of specialty clinical trial services, has appointed David Herron as the company’s next Chief Executive Officer, effective January 2, 2018. This …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
